Lamarque D, Dutreuil C, Dhumeaux D, Delchier J C
Service d'Hépatologie-Gastroentérologie and INSERM U99, Hôpital Henri Mondor, Creteil, France.
Dig Dis Sci. 1997 Apr;42(4):743-50. doi: 10.1023/a:1018851727844.
Gastric bicarbonate secretion might be modified in portal hypertension as a consequence of the intramucosal increase in prostaglandins and nitric oxide content. Therefore, we studied gastric bicarbonate secretion in control and portal hypertensive rats and investigated the role of prostaglandins and nitric oxide. Basal gastric bicarbonate secretion was studied in rats, using a gastric pH back-titration technique, two weeks after partial portal vein ligation or a sham operation. The effects of the following drugs were investigated: the prostaglandin synthase inhibitor indomethacin (5 mg/kg intravenously), prostaglandin (PGE2) (1 mg/kg intravenously), the nitric oxide synthase inhibitors N(G)-nitro-L-arginine methyl ester (L-NAME, 5 mg/kg intravenously) and N(G)-monomethyl-L-arginine (L-NMMA, 50 mg/kg intravenously), and the nitric oxide donor nitroprusside (5 mmol/liter in the gastric perfusate). Plasma leakage in the gastric wall was also measured after Evans blue dye injection in portal hypertensive and sham-operated rats pretreated by indomethacin (5 mg/kg, intravenously) and L-NAME (5 mg/kg, intravenously). Basal bicarbonate secretion was significantly increased in portal hypertensive rats as compared to controls. After indomethacin, the bicarbonate secretion was significantly reduced to a similar level in both groups. PGE2 increased bicarbonate secretion significantly more in portal hypertensive rats than in sham-operated rats. The NO synthase inhibitor L-NMMA significantly increased bicarbonate secretion in portal hypertensive rats only, while the other inhibitor, L-NAME, increased it significantly more in portal hypertensive than in the sham-operated rats. Plasma leakage in portal hypertensive rats, which was increased in the basal condition as compared to control, was further enhanced by indomethacin but not by L-NAME pretreatment. The nitric oxide donor significantly reduced bicarbonate secretion in portal hypertensive rats to reach a similar level as in sham-operated rats. Basal gastric bicarbonate secretion is increased in portal hypertensive rats. This could be due to an enhanced prostaglandin mucosal level. Nitric oxide, which reduces bicarbonate secretion, may contribute to limiting prostaglandin-induced bicarbonate overproduction.
由于前列腺素和一氧化氮含量在黏膜内增加,门静脉高压时胃碳酸氢盐分泌可能会发生改变。因此,我们研究了对照大鼠和门静脉高压大鼠的胃碳酸氢盐分泌情况,并探讨了前列腺素和一氧化氮的作用。在部分门静脉结扎或假手术后两周,采用胃pH反滴定技术研究大鼠的基础胃碳酸氢盐分泌。研究了以下药物的作用:前列腺素合成酶抑制剂吲哚美辛(静脉注射5mg/kg)、前列腺素(PGE2,静脉注射1mg/kg)、一氧化氮合酶抑制剂N(G)-硝基-L-精氨酸甲酯(L-NAME,静脉注射5mg/kg)和N(G)-单甲基-L-精氨酸(L-NMMA,静脉注射50mg/kg),以及一氧化氮供体硝普钠(胃灌流液中5mmol/L)。在门静脉高压大鼠和假手术大鼠中,静脉注射吲哚美辛(5mg/kg)和L-NAME(5mg/kg)预处理后,注射伊文思蓝染料,测量胃壁的血浆渗漏。与对照组相比,门静脉高压大鼠的基础碳酸氢盐分泌显著增加。吲哚美辛处理后,两组的碳酸氢盐分泌均显著降低至相似水平。PGE2使门静脉高压大鼠的碳酸氢盐分泌增加幅度显著大于假手术大鼠。一氧化氮合酶抑制剂L-NMMA仅使门静脉高压大鼠的碳酸氢盐分泌显著增加,而另一种抑制剂L-NAME使门静脉高压大鼠的碳酸氢盐分泌增加幅度显著大于假手术大鼠。与对照组相比,门静脉高压大鼠基础状态下的血浆渗漏增加,吲哚美辛预处理可进一步增强血浆渗漏,但L-NAME预处理则无此作用。一氧化氮供体显著降低门静脉高压大鼠的碳酸氢盐分泌,使其达到与假手术大鼠相似的水平。门静脉高压大鼠的基础胃碳酸氢盐分泌增加。这可能是由于前列腺素在黏膜中的水平升高所致。一氧化氮可降低碳酸氢盐分泌,可能有助于限制前列腺素诱导的碳酸氢盐过度产生。